IV Adjustments: CrCl > 50: 20 mg BID CrCl < 50: 20 mg daily PO Adjustments: CrCl > 60: 20 mg daily or BID CrCl 30-60: 10-20 mg daily CrCl < 30: 10 mg daily or 20 mg QOD
Per policy, these drugs may be converted from IV to PO in patients who meet criteria.
famotidine (Pepcid)
may convert from IV to PO on a mg-to-mg basis.
2023 American Geriatrics Society Beers Criteria® for potentially inappropriate medication use in older adults.
Medication:
famotidine (Pepcid)
Criteria 2: Potentially inappropriate medication use in older adults due to drug–disease or drug–syndrome interactions that may exacerbate the disease or syndrome. (Table 3)
Drug(s) ⇆ disease or syndrome
H2-receptor antagonists ⇄ Delirium
Rationale
Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.
Recommendation
Avoid
Quality of evidence: Low, Strength of Recommendation: Strong
Criteria 5: medications that should be avoided or have their dosage reduced with varying levels of kidney function in older adults. (Table 6)
CrCl (mL/min) at which action is required
<50
Rationale
Mental status changes
Recommendation
Reduce dose
Quality of evidence: Moderate, Strength of Recommendation: Strong
Last updated: Sep. 19, 2025
Renal Adjustment Policy famotidine subject to adjustments by pharmacy.
Refrigerator item (injection)
(Brand)
• Indications
Comments
(Pepcid©)
or
20 mg q12h
CrCl > 50: 20 mg BID
CrCl < 50: 20 mg daily
PO Adjustments:
CrCl > 60: 20 mg daily or BID
CrCl 30-60: 10-20 mg daily
CrCl < 30: 10 mg daily or 20 mg QOD